CoreRx Overview
- Year Founded
-
2006

- Status
-
Private
- Employees
-
425

- Latest Deal Type
-
Debt
- Financing Rounds
-
14
- Investments
-
4
CoreRx General Information
Description
Operator of a contract development manufacturing organization (CDMO intended to serve pharmaceutical and biotechnology companies. The company provides comprehensive services for the development, manufacturing and testing of solid, liquid and semi-solid dosage forms, from pre-formulation work to final formulation development, enabling clients to maximize their investments, shorten development time and reduce overall costs.
Contact Information
Website
www.corerxpharma.comCorporate Office
- 14205 Myerlake Circle
- Clearwater, FL 33760
- United States
Corporate Office
- 14205 Myerlake Circle
- Clearwater, FL 33760
- United States
CoreRx Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
CoreRx Comparisons
Industry
Financing
Details
CoreRx Competitors (23)
One of CoreRx’s 23 competitors is Sterling Pharma Solutions, a Private Equity-Backed company based in Cramlington, United Kingdom.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Sterling Pharma Solutions | Private Equity-Backed | Cramlington, United Kingdom | ||||
Alcami | Private Equity-Backed | Wilmington, NC | ||||
Recipharm | Private Equity-Backed | Stockholm, Sweden | ||||
Pnp Pharmaceuticals | Private Equity-Backed | Burnaby, Canada | ||||
NextPharma | Private Equity-Backed | London, United Kingdom |
CoreRx Patents
CoreRx Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20190008779-A1 | Gemcabene compositions and methods of use thereof | Inactive | 11-May-2017 |
CoreRx Signals
CoreRx Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
CoreRx Investments (4)
CoreRx’s most recent deal was a Buyout/LBO with Societal CDMO for . The deal was made on 28-Feb-2024.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Societal CDMO | 28-Feb-2024 | Buyout/LBO | Pharmaceuticals | ||
Bend Bioscience | 11-Oct-2022 | Buyout/LBO | Drug Delivery | ||
Nucleo Life Sciences | 24-May-2021 | Buyout/LBO | Drug Discovery | ||
Production Joint Venture for TSX-002 ( CoreRx / TesoRx Pharma) | 28-Aug-2013 | Joint Venture | Drug Delivery |
CoreRx Affiliates
Subsidiaries (2)
Name | Industry | Location | Year Founded |
---|---|---|---|
Societal CDMO | Gainesville, GA | 2007 | |
Bend Bioscience | Bend, OR | 1998 |
CoreRx FAQs
-
When was CoreRx founded?
CoreRx was founded in 2006.
-
Where is CoreRx headquartered?
CoreRx is headquartered in Clearwater, FL.
-
What is the size of CoreRx?
CoreRx has 425 total employees.
-
What industry is CoreRx in?
CoreRx’s primary industry is BPO/Outsource Services.
-
Is CoreRx a private or public company?
CoreRx is a Private company.
-
What is CoreRx’s current revenue?
The current revenue for CoreRx is
. -
How much funding has CoreRx raised over time?
CoreRx has raised $24.8M.
-
Who are CoreRx’s investors?
Juna Equity Partners, JVC Investment Partners, and QHP Capital have invested in CoreRx.
-
Who are CoreRx’s competitors?
Sterling Pharma Solutions, Alcami, Recipharm, Pnp Pharmaceuticals, and NextPharma are some of the 23 competitors of CoreRx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »